The effects of curcumin on hepatic T2*MRI and liver enzymes in patients with β‐thalassemia major: a double‐blind randomized controlled clinical trial

Background: Curcumin present in turmeric has been considered due to its cancer-preventive features, antioxidant and anti-inflammatory properties. This double-blind, randomized, controlled clinical trial with a reasonable sample size and longer intervention period was conducted to investigate how oral curcumin affected cardiac and hepatic T2*MRI and liver enzymes in patients with β‐thalassemia major.Method: This clinical trial study was conducted on 171 patients over 5 years old. The subjects were randomly divided into a curcumin-treatment group and a placebo group to receive either curcumin capsules twice daily or placebo for 6 months. Patients were examined once a month for 6 months to receive capsules and measure the levels of alanine aminotransferase (ALT), aspartate transferase (AST), alkaline phosphatase (ALP), direct and total bilirubin, ferritin and cardiac and hepatic T2*MRI.Result: There was a significant decrease in levels of AST, ALT, ALP, and bilirubin (direct and total) in the curcumin group compared with the placebo group by the end of the study (p < 0.05). The levels of serum ferritin remained unchanged in both groups at the end of the follow‐up period (p > 0.05). No significant differences were observed between the curcumin and placebo groups at baseline values or at the end of the study of cardiac and hepatic T2*MRI and serum magnesium.Conclusion: Administration of curcumin has some beneficial effects on liver function by reducing liver enzymes in patients with beta-thalassemia major

The effectiveness of melodic intonation therapy on fundamental frequency and intensity in Persian autistic children’s speech

Background and Aim: Autism is a pervasive developmental disorder with several speech disorders such as prosodic and pragmatic impairments. Melodic intonation therapy (MIT) based on Albert et al. model (1973) is a rehabilitation method, developed on prosodic features. The aim of this study was to investigate the effects of MIT on Persian autistic children’s prosody.Methods: An easy version of MIT, adopted for Persian language was designed by researchers. Then, after a successful pilot study on a 10-years-old boy for one month, 13 subjects were selected for the main study. All the subjects were autistic, male, right-handed, 7-10-years-old Persian children studied for 48 sessions (16 weeks). Background information gathered from the parents by a questionnaire. As pre- and post-test, some assessments about children’s fundamental frequency (Fº) and intensity of the Persian vowel sounds and declarative and interrogative sentences were accomplished. The data analysis was done using Praat and SPSS softwares.Results: There was a statistically significant increase in acoustic features, such as intensity, and fundamental frequency of declarative and interrogative sentences; also all six vowels of Persian, excluding /â/ and /æ/ (p<0.05 for all).Conclusion: The widely reported unusual prosody in autistic children was quantified by this study, too. In addition, there was convincing evidence of the positive effects of melodic intonation therapy on acoustic features in Persian autistic children

The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy

Cancer immunotherapy harnesses the immune system by targeting tumor cells that express antigens recognized by immune system cells, thus leading to tumor rejection. These tumor-associated antigens include tumor-specific shared antigens, differentiation antigens, protein products of mutated genes and rearrangements unique to tumor cells, overexpressed tissue-specific antigens, and exogenous viral proteins. However, the development of effective therapeutic approaches has proven difficult, mainly because these tumor antigens are shielded, and cells primarily express self-derived antigens. Despite innovative and notable advances in immunotherapy, challenges associated with variable patient response rates and efficacy on select tumors minimize the overall effectiveness of immunotherapy. Variations observed in response rates to immunotherapy are due to multiple factors, including adaptative resistance, competency, and a diversity of individual immune systems, including cancer stem cells in the tumor microenvironment, composition of the gut microbiota, and broad limitations of current immunotherapeutic approaches. New approaches are positioned to improve the immune response and increase the efficacy of immunotherapies, highlighting the challenges that the current global COVID-19 pandemic places on the present state of immunotherapy